Filing Flows › Pacific Biosciences of California (PACB) › How it makes money
How Pacific Biosciences of California (PACB) makes money
Pacific Biosciences of California (PACB) made $40.6M of revenue in the third quarter 2026 (Q3 2026), +6% from a year earlier. Product revenue brought in $34.0M (84%); Service and other revenue brought in $6.6M (16%).
Drawing the Sankey…
Revenue by segment, Q3 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Product revenue | $34.0M | 83.8% | — | +4% |
| ↳ Consumables revenue | $20.8M | 51.3% | — | -2% |
| ↳ Instrument revenue | $13.2M | 32.5% | — | +16% |
| Service and other revenue | $6.6M | 16.2% | — | +12% |
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $40.6M | 100.0% |
| Income tax | $269K | 0.7% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $40.6M | +6% |
| Q2 2026 | $39.0M | -2% |
| Q1 2026 | $37.2M | +0.1% |
| Q4 2025 | $44.6M | +14% |
| Q3 2025 | $38.4M | -4% |
| Q2 2025 | $39.8M | +10% |
| Q1 2025 | $37.2M | -4% |
From Pacific Biosciences of California's 10-Q filed Nov 5, 2026 (on EDGAR).
Questions
How does Pacific Biosciences of California make money?
Pacific Biosciences of California (PACB) made $40.6M of revenue in the third quarter 2026 (Q3 2026), +6% from a year earlier. Product revenue brought in $34.0M (84%); Service and other revenue brought in $6.6M (16%).
What is Pacific Biosciences of California's biggest business?
Product revenue: $34.0M in the third quarter 2026, 84% of revenue, +4% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.